Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum W
DAK-Gesundheit tender for Healthcare & Medical, value not disclosed, published in November 2023.
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime
Contract description
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Insulin lispro, ATC A10AB04, A10AD04 f. d. Zeit 01.01.24 - 31.12.24 (zzgl. Verlängerungsoption 1x12 Monate)
Other tenders · DAK-Gesundheit
The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Winners and award dates are hidden on the public page. Sign up free to see them →
- ocds-ted-18904-2026Not disclosed16 Nov 2023 Healthcare
- ocds-ted-18894-2026-8Not disclosed16 Nov 2023 Healthcare
- ocds-ted-18894-2026-7Not disclosed16 Nov 2023 Healthcare
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime